4.1 Review

Non-invasive EEG evaluation in epilepsy diagnosis

Journal

EXPERT REVIEW OF NEUROTHERAPEUTICS
Volume 15, Issue 4, Pages 425-444

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/14737175.2015.1025382

Keywords

EEG; epilepsy; focal; generalized; hyperventilation; medication; photic stimulation; sleep deprivation

Funding

  1. Novartis
  2. Pfizer
  3. Eisai
  4. UCB
  5. GSK
  6. Cerbomed
  7. Desitin
  8. Hexal
  9. Medical Tribune
  10. EU
  11. DFG
  12. ESF
  13. CURE-Foundation
  14. DFG [KL 2254/1-1]
  15. University of Melbourne
  16. Janssen-Cilag
  17. GlaxoSmithKline
  18. UCB Pharma

Ask authors/readers for more resources

The EEG is an invaluable tool in the diagnosis of epilepsy which guides clinical management. It helps to determine if attacks are of epileptic origin, allows the estimation of the recurrence risk after a first seizure, aids in the diagnosis of the epilepsy syndrome and represents the gold standard in the presurgical evaluation of epilepsy. The EEG can also detect subclinical seizures as a cause of coma. In this review we discuss the sensitivity and specificity of the EEG, present the EEG findings and their significance in different epilepsy syndromes including focal and generalized epilepsies and describe the application of activation procedures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available